| |
| |
|
| Insider
Information: |
Coughlin Christopher J |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
11 |
|
| Direct
Shares |
339,683 |
|
|
Indirect Shares
|
17,342 |
|
|
| Direct
Value |
$11,630,867 |
|
|
|
Indirect Value
|
$3,201,105 |
|
|
| Total
Shares |
357,025 |
|
|
| Total
Value |
$14,831,972 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -5.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Interpublic Group of Companies |
IPG |
CFO and COO, Director |
2004-05-18 |
81,842 |
2004-05-18 |
0 |
Premium* |
|
|
Dun & Bradstreet Corp |
DNB |
Director |
2017-03-10 |
16,535 |
2017-03-10 |
800 |
Premium* |
|
|
Johnson Controls International plc |
JCI |
EVP and CFO |
2010-11-26 |
88,558 |
2005-03-07 |
0 |
Premium* |
|
|
Covidien Plc |
COV |
Director |
2015-01-26 |
0 |
2015-01-26 |
0 |
Premium* |
|
|
Plx Pharma Inc |
PLXP |
Director |
2014-03-18 |
109,309 |
|
0 |
Premium* |
|
|
Allergan plc |
AGN |
Director |
2020-05-08 |
0 |
2020-05-08 |
16,542 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2021-07-21 |
0 |
2014-07-22 |
0 |
Premium* |
|
|
Hologic Inc |
HOLX |
Director |
2017-03-08 |
7,633 |
|
0 |
Premium* |
|
|
Prestige Brands Holdings Inc |
PBH |
Director |
2022-08-02 |
13,218 |
2019-07-30 |
0 |
Premium* |
|
|
Centene Corp |
CNC |
Director |
2024-03-31 |
22,588 |
2022-02-07 |
0 |
Premium* |
|
|
Karuna Therapeutics, Inc. |
KRTX |
|
2024-03-18 |
0 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
179 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| COV |
Covidien Plc |
Director |
– • – |
2007-06-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
61,417 |
|
- |
|
| PLXP |
Plx Pharma Inc |
Director |
– • – |
2014-03-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
107,226 |
|
- |
|
| HOLX |
Hologic Inc |
Director |
– • – |
2016-03-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,000 |
|
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2007-03-29 |
4 |
A |
$90.14 |
$698 |
D/D |
8 |
2,799 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2007-06-15 |
4 |
A |
$101.10 |
$782 |
D/D |
8 |
3,135 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
– • – |
2007-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
8 |
56,950 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
– • – |
2008-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
8 |
50,248 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
• • – |
2013-05-03 |
4 |
A |
$64.35 |
$515 |
D/D |
8 |
47,302 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2007-09-17 |
4 |
A |
$98.15 |
$856 |
D/D |
9 |
3,433 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2007-12-14 |
4 |
A |
$91.08 |
$858 |
D/D |
9 |
3,442 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
– • – |
2011-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9 |
44,392 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
– • – |
2010-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10 |
43,986 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
• • – |
2012-08-16 |
4 |
A |
$57.59 |
$576 |
D/D |
10 |
46,107 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
– • – |
2011-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
11 |
44,023 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
– • – |
2011-08-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11 |
44,403 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
– • – |
2012-05-07 |
4 |
A |
$54.25 |
$597 |
D/D |
11 |
46,097 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
• • – |
2013-08-15 |
4 |
A |
$61.85 |
$680 |
D/D |
11 |
47,773 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
• • – |
2012-12-27 |
4 |
A |
$57.35 |
$688 |
D/D |
12 |
46,132 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
• • – |
2014-02-20 |
4 |
A |
$71.28 |
$855 |
D/D |
12 |
47,798 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2008-03-17 |
4 |
A |
$80.38 |
$1,029 |
D/D |
13 |
3,802 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2008-06-16 |
4 |
A |
$90.74 |
$1,134 |
D/D |
13 |
3,815 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2008-09-15 |
4 |
A |
$92.80 |
$1,248 |
D/D |
13 |
4,173 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
– • – |
2010-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
13 |
43,999 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
– • – |
2010-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
13 |
44,012 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
• • – |
2012-11-05 |
4 |
A |
$55.65 |
$723 |
D/D |
13 |
46,120 |
0 |
- |
|
179 Records found
|
|
Page 1 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
